ArticleJournal of cellular and molecular medicine2020

EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.

Ming-Qiang Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.